FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis
Abstract Background There is no consensus about the effective dosages of melatonin in cancer management, thus, it is imperative to fully understand the dose-dependent responsiveness of cancer cells to melatonin and the underlying mechanisms. Methods Head and neck squamous cell carcinoma (HNSCC) cell...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-03-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13046-021-01888-9 |
| _version_ | 1818677603584704512 |
|---|---|
| author | Liwei Lang Yuanping Xiong Nestor Prieto-Dominguez Reid Loveless Caleb Jensen Chloe Shay Yong Teng |
| author_facet | Liwei Lang Yuanping Xiong Nestor Prieto-Dominguez Reid Loveless Caleb Jensen Chloe Shay Yong Teng |
| author_sort | Liwei Lang |
| collection | DOAJ |
| description | Abstract Background There is no consensus about the effective dosages of melatonin in cancer management, thus, it is imperative to fully understand the dose-dependent responsiveness of cancer cells to melatonin and the underlying mechanisms. Methods Head and neck squamous cell carcinoma (HNSCC) cells with or without melatonin treatment were used as a research platform. Gene depletion was achieved by short hairpin RNA, small interfering RNA, and CRISPR/Cas9. Molecular changes and regulations were assessed by Western blotting, quantitative RT-PCR (qRT-PCR), immunohistochemistry, and chromatin Immunoprecipitation coupled with qPCR (ChIP-qPCR). The therapeutic efficacy of FGF19/FGFR4 inhibition in melatonin-mediated tumor growth and metastasis was evaluated in orthotopic tongue tumor mice. Results The effect of melatonin on controlling cell motility and metastasis varies in HNSCC cells, which is dose-dependent. Mechanistically, high-dose melatonin facilitates the upregulation of FGF19 expression through activating endoplasmic stress (ER)-associated protein kinase RNA-like endoplasmic reticulum kinase (PERK)-Eukaryotic initiation factor 2 alpha (eIF2α)-activating transcription factor 4 (ATF4) pathway, which in turn promotes FGFR4-Vimentin invasive signaling and attenuates the role of melatonin in repressing metastasis. Intriguingly, following long-term exposure to high-dose melatonin, epithelial HNSCC cells revert the process towards mesenchymal transition and turn more aggressive, which is enabled by FGF19/FGFR4 upregulation and alleviated by genetic depletion of the FGF19 and FGFR4 genes or the treatment of FGFR4 inhibitor H3B-6527. Conclusions Our study gains novel mechanistic insights into melatonin-mediated modulation of FGF19/FGFR4 signaling in HNSCC, demonstrating that activating this molecular node confines the role of melatonin in suppressing metastasis and even triggers the switch of its function from anti-metastasis to metastasis promotion. The blockade of FGF19/FGFR4 signaling would have great potential in improving the efficacy of melatonin supplements in cancer treatment. |
| first_indexed | 2024-12-17T09:02:00Z |
| format | Article |
| id | doaj.art-6e0668c9c3b948c5ad78f147362b727d |
| institution | Directory Open Access Journal |
| issn | 1756-9966 |
| language | English |
| last_indexed | 2024-12-17T09:02:00Z |
| publishDate | 2021-03-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Experimental & Clinical Cancer Research |
| spelling | doaj.art-6e0668c9c3b948c5ad78f147362b727d2022-12-21T21:55:41ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662021-03-0140111410.1186/s13046-021-01888-9FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasisLiwei Lang0Yuanping Xiong1Nestor Prieto-Dominguez2Reid Loveless3Caleb Jensen4Chloe Shay5Yong Teng6Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta UniversityDepartment of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta UniversityDepartment of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta UniversityDepartment of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta UniversityDepartment of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta UniversityDepartment of Pediatrics, Emory Children’s Center, Emory UniversityDepartment of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta UniversityAbstract Background There is no consensus about the effective dosages of melatonin in cancer management, thus, it is imperative to fully understand the dose-dependent responsiveness of cancer cells to melatonin and the underlying mechanisms. Methods Head and neck squamous cell carcinoma (HNSCC) cells with or without melatonin treatment were used as a research platform. Gene depletion was achieved by short hairpin RNA, small interfering RNA, and CRISPR/Cas9. Molecular changes and regulations were assessed by Western blotting, quantitative RT-PCR (qRT-PCR), immunohistochemistry, and chromatin Immunoprecipitation coupled with qPCR (ChIP-qPCR). The therapeutic efficacy of FGF19/FGFR4 inhibition in melatonin-mediated tumor growth and metastasis was evaluated in orthotopic tongue tumor mice. Results The effect of melatonin on controlling cell motility and metastasis varies in HNSCC cells, which is dose-dependent. Mechanistically, high-dose melatonin facilitates the upregulation of FGF19 expression through activating endoplasmic stress (ER)-associated protein kinase RNA-like endoplasmic reticulum kinase (PERK)-Eukaryotic initiation factor 2 alpha (eIF2α)-activating transcription factor 4 (ATF4) pathway, which in turn promotes FGFR4-Vimentin invasive signaling and attenuates the role of melatonin in repressing metastasis. Intriguingly, following long-term exposure to high-dose melatonin, epithelial HNSCC cells revert the process towards mesenchymal transition and turn more aggressive, which is enabled by FGF19/FGFR4 upregulation and alleviated by genetic depletion of the FGF19 and FGFR4 genes or the treatment of FGFR4 inhibitor H3B-6527. Conclusions Our study gains novel mechanistic insights into melatonin-mediated modulation of FGF19/FGFR4 signaling in HNSCC, demonstrating that activating this molecular node confines the role of melatonin in suppressing metastasis and even triggers the switch of its function from anti-metastasis to metastasis promotion. The blockade of FGF19/FGFR4 signaling would have great potential in improving the efficacy of melatonin supplements in cancer treatment.https://doi.org/10.1186/s13046-021-01888-9FGF19/FGFR4 axisMelatoninER stressMetastasesH3B-6527HNSCC |
| spellingShingle | Liwei Lang Yuanping Xiong Nestor Prieto-Dominguez Reid Loveless Caleb Jensen Chloe Shay Yong Teng FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis Journal of Experimental & Clinical Cancer Research FGF19/FGFR4 axis Melatonin ER stress Metastases H3B-6527 HNSCC |
| title | FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis |
| title_full | FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis |
| title_fullStr | FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis |
| title_full_unstemmed | FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis |
| title_short | FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis |
| title_sort | fgf19 fgfr4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis |
| topic | FGF19/FGFR4 axis Melatonin ER stress Metastases H3B-6527 HNSCC |
| url | https://doi.org/10.1186/s13046-021-01888-9 |
| work_keys_str_mv | AT liweilang fgf19fgfr4signalingaxisconfinesandswitchestheroleofmelatonininheadandneckcancermetastasis AT yuanpingxiong fgf19fgfr4signalingaxisconfinesandswitchestheroleofmelatonininheadandneckcancermetastasis AT nestorprietodominguez fgf19fgfr4signalingaxisconfinesandswitchestheroleofmelatonininheadandneckcancermetastasis AT reidloveless fgf19fgfr4signalingaxisconfinesandswitchestheroleofmelatonininheadandneckcancermetastasis AT calebjensen fgf19fgfr4signalingaxisconfinesandswitchestheroleofmelatonininheadandneckcancermetastasis AT chloeshay fgf19fgfr4signalingaxisconfinesandswitchestheroleofmelatonininheadandneckcancermetastasis AT yongteng fgf19fgfr4signalingaxisconfinesandswitchestheroleofmelatonininheadandneckcancermetastasis |